Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development (Q44956263)

7 December 2017

title

Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development (English)

1 reference

7 December 2017

Ankur Saxena

3

0 references

Chad A. Cowan

1

object named as

Chad A Cowan

1 reference

7 December 2017

Nobuhiko Yokoyama

2

1 reference

7 December 2017

Michael J Chumley

4

1 reference

7 December 2017

Robert E Silvany

5

1 reference

7 December 2017

Linda A Baker

6

1 reference

7 December 2017

Deepak Srivastava

7

1 reference

7 December 2017

Mark Henkemeyer

8

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

published in

Developmental Biology

1 reference

7 December 2017

volume

271

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

263-271

1 reference

Vascular patterning by Eph receptor tyrosine kinases and ephrins

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Molecular control of arterial-venous blood vessel identity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Eph receptors and ephrin ligands. essential mediators of vascular development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

EphB receptors and ephrinB ligands: regulators of vascular assembly and homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Early events in valvulogenesis: a signaling perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

The ephrins and Eph receptors in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Ephrins in reverse, park and drive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Molecular regulation of atrioventricular valvuloseptal morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Molecular mechanisms of vasculogenesis and embryonic angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Ephrins and their Eph receptors: multitalented directors of embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Nuk controls pathfinding of commissural axons in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Ephrins are not only unattractive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Mechanisms and functions of Eph and ephrin signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Mechanisms of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Growth factor signaling pathways in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Multiple roles of EPH receptors and ephrins in neural development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

Vascular-specific growth factors and blood vessel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YDBIO.2004.03.026

10.1016/J.YDBIO.2004.03.026

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference